VITA 34 AG | Balance Sheet

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
2,927.00
3,730.00
2,082.00
2,813.00
4,180.00
-
Total Accounts Receivable
2,762.00
3,884.00
3,748.00
3,799.00
3,806.00
-
Inventories
550.00
297.00
423.00
291.00
500.00
-
Other Current Assets
2,093.00
2,050.00
1,052.00
640.00
182.00
-
Total Current Assets
8,332.00
9,961.00
7,305.00
7,543.00
8,668.00
-
Net Property, Plant & Equipment
4,450.00
4,284.00
4,839.00
4,721.00
6,329.00
-
Total Investments and Advances
552.00
1,096.00
4,488.00
3,792.00
3,540.00
-
Long-Term Note Receivable
1,177.00
1,095.00
950.00
888.00
1,103.00
-
Intangible Assets
21,117.00
20,620.00
26,200.00
25,091.00
39,859.00
-
Other Assets
-
-
-
1,387.00
2,462.00
-
Total Assets
35,628.00
39,029.00
45,909.00
45,475.00
61,961.00
-
ST Debt & Current Portion LT Debt
140.00
87.00
613.00
601.00
2,085.00
Accounts Payable
1,127.00
696.00
1,322.00
1,162.00
949.00
Income Tax Payable
58.00
239.00
159.00
7.00
11.00
Other Current Liabilities
2,633.00
2,819.00
2,963.00
3,452.00
5,148.00
Total Current Liabilities
3,958.00
3,841.00
5,057.00
5,222.00
8,193.00
Long-Term Debt
1,150.00
1,104.00
3,116.00
2,482.00
8,032.00
Provision for Risks & Charges
54.00
-
-
-
-
Deferred Taxes
31.00
463.00
1,704.00
1,665.00
3,934.00
Other Liabilities
8,169.00
8,367.00
9,113.00
9,448.00
11,269.00
Total Liabilities
13,362.00
15,748.00
21,117.00
20,870.00
31,428.00
Common Equity (Total)
21,094.00
22,072.00
23,674.00
23,648.00
29,526.00
Total Shareholders' Equity
21,094.00
22,072.00
23,674.00
23,648.00
29,526.00
Total Equity
21,292.00
22,160.00
23,756.00
23,648.00
29,643.00
Liabilities & Shareholders' Equity
35,628.00
39,029.00
45,909.00
45,475.00
61,961.00
Accumulated Minority Interest
198.00
88.00
82.00
-
117.00
Non-Equity Reserves
974.00
1,121.00
1,036.00
957.00
890.00

About VITA 34

View Profile
Address
Deutscher Platz 5a
Leipzig Sachsen (Saxony) 04103
Germany
Employees -
Website http://www.vita34.de
Updated 07/08/2019
Vita 34 AG engages in the collection and storage of umbilical cord blood and stem cells. It operates through Stem Cell Banking segment. The Stem Cell Banking segment collects, processes, and stores stem cells from umbilical cord blood and tissue, and develops cell therapy processes.